Prudential Financial
VERV

Prudential Financial’s Verve Therapeutics VERV Stock Holding History

Prudential Financial’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-74,815
Closed -$362K – 2715
2024
Q3 		$362K Buy
74,815
+13,000
+21% +$75.5K ﹤0.01% 2344
2024
Q2 		$302K Buy
+61,815
New +$389K ﹤0.01% 2353
2022
Q1 		– Sell
-54,965
Closed -$2.16M – 2700
2021
Q4 		$2.16M Buy
+54,965
New +$2.31M ﹤0.01% 1491

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Prudential Financial's VERV Position: Q4 2024 in Review

Prudential Financial sold out of Verve Therapeutics (VERV) in Q4 2024, closing a stake of 74,815 shares — an estimated $362K sold.

Prudential Financial first reported a position in VERV in Q4 2021 and held it in 3 quarters. The position peaked at $2.16M in Q4 2021. 166 funds tracked by Wall St. Rank hold VERV as of Q4 2024.

  • Prudential Financial reported no remaining Verve Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 74,815 Verve Therapeutics shares in Q4 2024, an estimated $362K.
  • Prudential Financial first reported a position in Verve Therapeutics in Q4 2021 and held it in 3 quarters.
  • Prudential Financial's Verve Therapeutics position peaked at $2.16M in Q4 2021.
  • 166 funds tracked by Wall St. Rank held Verve Therapeutics as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.